Equity
Startup Battlefield winner Salva Health is changing the game in breast cancer detection
Apr 2, 2025
Valentina Agudelo, co-founder and CEO of Salva Health, is revolutionizing breast cancer detection with the innovative Julieta device. She identified alarming survival rate disparities in Latin America, leading to her groundbreaking efforts. The conversation covers how Julieta makes early detection accessible in underserved communities, the unique hardware-as-a-service model, and plans for expansion into other medical conditions. Valentina shares insights from her Startup Battlefield experience and the challenges of securing funding for female-led startups.
23:47
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Salva Health's Julieta device revolutionizes early breast cancer detection by providing painless, portable screenings and delivering results quickly via an app.
- The company faces unique funding challenges due to its focus on women's health, requiring persistence and strategic partnerships to secure necessary resources for growth.
Deep dives
Empowering Women's Health Care Access
Salva Health is dedicated to improving access to health care for women in rural areas by focusing on early disease detection. Their innovative device, Pulieta, enables painless and portable breast cancer screenings, addressing significant access barriers found with traditional methods. In Colombia, less than 5% of women receive regular preventive screenings, largely due to geographical, financial, and psychological barriers. The company's mission is to provide screenings directly to underserved women, ensuring they receive the care they need without traveling long distances.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
